Biotechgate Strengthens its Presence in North America With Sales Team Expansion

Zurich, Switzerland, December 2023 – Biotechgate, a unique business development and licensing platform for the life sciences industry, announces that it has appointed Bill Colihan and David Tucker as BD Directors to strengthen Biotechgate’s expansion in North America.

Both BD directors are located in the USA and will take care of the North American market. Bill Colihan has extensive experience in the business development of innovative information services and previously served as President of Knowledge Express. He holds a BA from the University of Delaware and an MBA from Villanova University.

David Tucker combines an investment banking background with 15 years of experience in life science business development, leadership and consulting. He graduated from Colorado State University with an MBA and is currently pursuing a Master’s degree in Biotechnology from Johns Hopkins University.

Together with the existing sales teams in Asia and Europe, Biotechgate now covers all time zones and thus enables an even better service for all customers and partners.  “I’m thrilled to welcome Bill and David to the team as we continue to grow our presence and better serve our North America-based clients. Both possess strong skillsets and a wealth of previous experience in BD intelligence that will be a valuable asset to our company going forward,” said Patrik Frei, chief executive officer of Biotechgate / Venture Valuation.

If you wish to get in touch with the North American sales team, you can reach out through the Biotechgate website or by connecting with them on LinkedIn:

About Biotechgate:

Biotechgate is a leading business development and licensing database for the entire life science industry, offering a wealth of information on over 70,000 life science company profiles. Thanks to its unique data-sourcing process, the profiles include company descriptions, contact information, product pipeline information, financing rounds, and management details, making it an invaluable resource for life sciences start-ups, pharma companies, investors, and other industry professionals. Biotechgate also features 30,000 licensing deals and a clinical trials database containing over 800,000 records from registries around the world.